LdIL-2 treatment in ASD: a novel immunotherapeutic approach targeting Th/Treg dysfunction and neuroinflammation.
Li M, Kui X, Yang S, Nie Z, Chen H, Yao P, Xu X, Shen C, Li Z, Zhao H, Wen J, Huang X, Yang J, Yan J, Wang P, Li B, Cao X.
Li M, et al.
Transl Psychiatry. 2025 Oct 6;15(1):376. doi: 10.1038/s41398-025-03609-8.
Transl Psychiatry. 2025.
PMID: 41053009
Free PMC article.
Neuroinflammatory proteins in cerebrospinal fluid were assessed using proteomic analysis. Furthermore, CD25(+) Treg cells were depleted using PC61, followed by LdIL-2 intervention, to determine the role of Treg cells in LdIL-2-treated BTBR mice. ...Central ne …
Neuroinflammatory proteins in cerebrospinal fluid were assessed using proteomic analysis. Furthermore, CD25(+) Treg cells were deplet …